Dobutamine Hydrochloride
Who holds supplier records for Dobutamine Hydrochloride? 8 organisations hold a current record for Dobutamine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Italy (2), Germany (2) and France (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dobutamine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dobutamine-hydrochloride
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dobutamine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Aragen Life SciencesIndiaCEPActive DMF 42602 · latest filing Nov 2025
- HAINAN POLY PHARM CO LTDCEP Company GMP cert on recordActive DMF 35217 · latest filing Sept 2020
- RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAItalyCEP Company GMP cert on recordActive DMF 9762 · latest filing Jul 1992
- SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHGermanyCEP Company GMP cert on recordActive DMF 11023 · latest filing Aug 1994
- CHEMWERTH INCFranceActive DMF 8856 · latest filing Nov 1990
- ItalyCEP Company GMP cert on record
- GermanyCEP Company GMP cert on record
- D. K. PHARMA CHEM PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (7)
Certificates of Suitability on the EDQM register for Dobutamine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HAINAN POLY PHARM. CO. LTD Haikou | CN | CEP 2020-415 - Rev 01 Dobutamine hydrochloride | Jun 2026 | Inspected Mar 2024 Netherlands |
| BIOINDUSTRIA L.I.M. S.P.A. Novi Ligure | IT | CEP 2004-261 - Rev 02 Dobutamine hydrochloride | Aug 2025 | Inspected Apr 2025 Italy |
| D. K. PHARMA CHEM PRIVATE LIMITED Badlapur | IN | CEP 2023-369 - Rev 00 Dobutamine hydrochloride | May 2025 | Inspected Mar 2024 Sweden |
| RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. Milano | IT | CEP 2017-291 - Rev 01 Dobutamine hydrochloride | Mar 2024 | Inspected Feb 2026 Italy |
| ARAGEN LIFE SCIENCES LIMITED Hyderabad | IN | CEP 2020-180 - Rev 03 Dobutamine hydrochloride, Process-2 | Oct 2023 | — |
| EXCELLA GMBH & CO. KG Feucht | DE | R1-CEP 2002-173 - Rev 03 Dobutamine hydrochloride | Dec 2016 | — |
| SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH Minden | DE | R1-CEP 2006-273 - Rev 01 Dobutamine hydrochloride | Dec 2015 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (8)
Organisations whose Type II DMFs for Dobutamine Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 8 historical records
- SOCHINAZ SAInactive DMF 11083 · filed Sept 1994
- IROTEC LABORATORIESInactive DMF 10706 · filed Jan 1994
- CHEMSYN SCIENCE LABORATORIESInactive DMF 10296 · filed Jun 1993
- Hungary · Inactive DMF 10097 · filed Feb 1993
- HUHTAMAKI OY LEIRAS PHARMACEUTICALSInactive DMF 9888 · filed Oct 1992
- SUMIKA FINE CHEMICALS CO LTDInactive DMF 9369 · filed Sept 1991
- RAYLO CHEMICALSInactive DMF 9024 · filed Mar 1991
- USA · Inactive DMF 8589 · filed Jun 1990
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Dobutamine Hydrochloride is a sympathomimetic drug used to treat heart failure and cardiogenic shock by increasing myocardial contractility. It works by stimulating beta-1 adrenergic receptors, resulting in improved cardiac output.
Chemical identity
- IUPAC name
- 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol;hydrochloride
- Canonical SMILES
- CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O.Cl
- InChIKey
- BQKADKWNRWCIJL-UHFFFAOYSA-N
- Synonyms
- Dobutrex API, dl-dobutamine hydrochloride, dobutamine hcl, dobutrex, inotrex, nsc-299583
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- beta-Adrenergic Agonist
- Mechanism of action
- Adrenergic beta-Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dobutamine Hydrochloride?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Dobutamine Hydrochloride: Aragen Life Sciences (India), HAINAN POLY PHARM CO LTD, RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA (Italy), SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH (Germany), CHEMWERTH INC (France), BIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI SPA (Italy), EXCELLA GMBH AND CO KG (Germany) and D. K. PHARMA CHEM PRIVATE LIMITED (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dobutamine Hydrochloride Drug Master Files are active?
Aragen Life Sciences (DMF 42602), HAINAN POLY PHARM CO LTD (DMF 35217), RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA (DMF 9762), SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH (DMF 11023) and CHEMWERTH INC (DMF 8856). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Dobutamine Hydrochloride records mean?
8 organisations have only inactive Type II DMFs for Dobutamine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Dobutamine Hydrochloride have a European Certificate of Suitability?
Yes. 7 organisations hold a valid CEP for Dobutamine Hydrochloride on the EDQM register, including HAINAN POLY PHARM. CO. LTD Haikou (CN), BIOINDUSTRIA L.I.M. S.P.A. Novi Ligure (IT), D. K. PHARMA CHEM PRIVATE LIMITED Badlapur (IN), RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. Milano (IT), ARAGEN LIFE SCIENCES LIMITED Hyderabad (IN) and EXCELLA GMBH & CO. KG Feucht (DE) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Dobutamine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dobutamine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.